The Department of Health has announced a joint settlement with Goldshield (Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Limited) over claims brought against the company for allegedly attempting to price fix in an anti-competitive cartel when supplying generic drugs to the NHS.

Under the terms of the settlement, Goldshield has agreed, without admission of liability, to pay the NHS£4m and co-operate with ongoing civil claims.

Click here for more details